Generex Biotechnology Corp. (fka GNBTQ)

[namtae]

Plenty of worthless penny stocks have had their shares hyped up and promoted making certain investors lots of money

However, eventually when the reality is exposed, they will leave many investors behind holding the bag for big losses.

To date, aside from all the PR & lame amateur research reports etc, GNBT has shown through its recent 10Q SEC filing the following:

Rev $1m

NET LOSS $11,000,000

Working Capital Deficit $25,000,000

Thats the real bottom line. Until proven otherwise, the rest is fluff that may cause investors to lose $millions drinking the koolaid